Growth Metrics

Sanofi (SNY) Short-term Investments (2016 - 2021)

Sanofi's Short-term Investments history spans 13 years, with the latest figure at $12.5 million for Q4 2021.

  • On a quarterly basis, Short-term Investments fell 93.18% to $12.5 million in Q4 2021 year-over-year; TTM through Dec 2021 was $12.5 million, a 93.18% decrease, with the full-year FY2021 number at $12.5 million, down 93.18% from a year prior.
  • Short-term Investments hit $12.5 million in Q4 2021 for Sanofi, down from $182.9 million in the prior quarter.
  • Over the last five years, Short-term Investments for SNY hit a ceiling of $227.1 million in Q4 2018 and a floor of $12.5 million in Q4 2021.
  • Historically, Short-term Investments has averaged $132.0 million across 5 years, with a median of $147.0 million in 2019.
  • Biggest five-year swings in Short-term Investments: skyrocketed 170.86% in 2017 and later crashed 93.18% in 2021.
  • Tracing SNY's Short-term Investments over 5 years: stood at $90.7 million in 2017, then surged by 150.53% to $227.1 million in 2018, then plummeted by 35.28% to $147.0 million in 2019, then grew by 24.42% to $182.9 million in 2020, then crashed by 93.18% to $12.5 million in 2021.
  • Business Quant data shows Short-term Investments for SNY at $12.5 million in Q4 2021, $182.9 million in Q4 2020, and $147.0 million in Q4 2019.